Build a Decision-Ready Clinical Development Plan That Aligns Science, Strategy, Risk, and Investment.
Table of Contents
Chapter 1. Clinical Development Plan: Purpose, Scope, and Governance
1.1 What a Clinical Development Plan Must Decide
1.2 Core Inputs: Product Profile, Science, Regulatory Context, and Commercial Need
1.3 Governance Model: Owners, Forums, and Decision Rights
1.4 Core Deliverables, Planning Cadence, and Version Control
1.5 Checklist: Is the Clinical Development Plan Decision-Ready?
Chapter 2. Indication Strategy and Development Thesis
2.1 Defining Target Indications and Patient Segments
2.2 Prioritizing Indications by Unmet Need, Biology, Feasibility, and Value
2.3 Sequencing Initial, Expansion, and Lifecycle Indications
2.4 Translating the Target Product Profile into Development Choices
2.5 Indication Strategy Template
Chapter 3. Evidence Strategy, Endpoints, and Study Objectives
3.1 Defining the Required Evidence Package
3.2 Primary, Secondary, Exploratory, Safety, and Patient-Reported Endpoints
3.3 Biomarkers, Subgroups, and Companion Diagnostic Considerations
3.4 Endpoint Feasibility, Regulatory Acceptability, and Commercial Relevance
3.5 Endpoint Selection Checklist
Chapter 4. Trial Sequencing and Study Design
4.1 Designing the Phase 1, Phase 2, and Phase 3 Pathway
4.2 Dose Selection, Proof of Concept, and Signal Detection
4.3 Adaptive, Seamless, Basket, Umbrella, and Platform Trial Options
4.4 Country, Site, Patient Recruitment, and Operational Feasibility Planning
4.5 Trial Sequence Planning Template
Chapter 5. Assumptions, Scenarios, and Development Risk
5.1 Building the Core Assumption Set
5.2 Scientific, Clinical, Regulatory, Operational, and Commercial Risks
5.3 Base Case, Upside Case, and Downside Case Scenarios
5.4 Sensitivity Analysis for Cost, Timeline, Probability of Success, and Value
5.5 Assumption and Risk Register Template
Chapter 6. Regulatory, CMC, Safety, and Cross-Functional Integration
6.1 Aligning the Clinical Plan with the Regulatory Strategy
6.2 Integrating CMC Readiness, Product Supply, and Formulation Needs
6.3 Safety Strategy, Pharmacovigilance, and Risk Management Planning
6.4 Medical Affairs, Market Access, and Commercial Input into the Plan
6.5 Cross-Functional Integration Checklist
Chapter 7. Decision Gates, Investment Cases, and Governance Reviews
7.1 Defining Decision Gates Across the Development Pathway
7.2 Go, No-Go, Pause, Pivot, and Partnering Decisions
7.3 Building the Clinical Development Investment Case
7.4 Preparing Governance Materials for Executive and Board Review
7.5 Decision Gate Review Template
Chapter 8. Implementation Roadmap and External Support Options
8.1 Building the Clinical Development Plan Roadmap
8.2 Internal Capabilities, Operating Cadence, and Execution Discipline
8.3 Support from Large Consulting Firms
8.4 Specialist Advisors, CROs, Regulatory Experts, and Functional Consultants
8.5 Independent Management Consultants Through Umbrex
